Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Mirosa Dellagiovanna"'
Autor:
Carlo Cerra, Mirosa Dellagiovanna, Simona Migliazza, Roberto Tettamanti, Corrado Zuliani, Roberto Ravasio, Delia Colombo, Claudia Pitotti, Emanuela Zagni
Publikováno v:
Global & Regional Health Technology Assessment, Vol 3, Iss 3 (2016)
Externí odkaz:
https://doaj.org/article/622d44c942504a3aafafbc2321c8e8bc
Publikováno v:
PharmacoEconomics Italian Research Articles. 10:49-52
Autor:
Paolo Pedrazzoli, Simona Secondino, Silvia Vecchio, Mirosa Dellagiovanna, Simona Dalle Carbonare, Chiara Paglino, Michele Tringali, Vittorio Perfetti
Publikováno v:
PharmacoEconomics Italian Research Articles. 17
Biosimilars of hemopoietic growth factors present an important saving opportunity in oncology. However, while pharmacologists are aware of their potential benefits, biosimilars are still under-used in Italy. Improved information and guided clinical e
Publikováno v:
PharmacoEconomics Italian Research Articles. 8:3-17
Cardiovascular diseases remain the major cause of death in the world, with extensive public health expenditures. Lipid lowering agents are widely used for prevention, among which statins are dominant. The statins market is steadily expanding in Italy
Autor:
Claudia Pitotti, Roberto Ravasio, Simona Migliazza, Mirosa Dellagiovanna, Emanuela Zagni, Delia Colombo, Roberto Tettamanti, Carlo Cerra, Corrado Zuliani
Publikováno v:
Global & Regional Health Technology Assessment: Italian; Northern Europe and Spanish. 3:GRHTA.5000231